Bottom line
HELX vs FTXH: the short answer
HELX (Franklin Genomic Advancements ETF) and FTXH (First Trust Nasdaq Pharmaceuticals ETF) are quite different portfolios: only about 18% of their top holdings (by weight) are shared.
HELX is cheaper at 0.5% vs 0.6% — a difference of $10 a year per $10,000 invested.
Over five years, FTXH returned +6.5% a year vs −3.8% for HELX.
Updated Nov 19, 2026
HELX vs FTXH side by side
| HELX | FTXH | |
|---|---|---|
| Type | ETF | ETF |
| Fund family | Franklin Templeton | First Trust |
| Category | Health Care Sector | Health Care Sector |
| Expense ratio | 0.5% | 0.6% |
| Annual cost per $10k | $50 | $60 |
| 10-yr cost on $10k (prospectus) | $629 | — |
| Max front load | None | None |
| 12b-1 fee | 0% | 0% |
| 1-yr return | +25.9% | +24.0% |
| 5-yr return (annualized) | −3.8% | +6.5% |
| 10-yr return (annualized) | — | — |
| Best quarter | +19.6% | +18.3% |
| Worst quarter | −23.7% | −17.4% |
| Net assets (fund) | $27.9M | $36.2M |
| Number of holdings | 63 | 51 |
| Portfolio turnover | 29% | 35% |
| Returns as of | Dec 31, 2025 | Dec 31, 2025 |
Source: SEC Form N-PORT and fund prospectuses
Year-by-year returns
| Year | HELX | FTXH | Difference |
|---|---|---|---|
| 2025 | +25.9% | +24.0% | +1.9% |
| 2024 | −5.1% | +3.0% | −8.0% |
| 2023 | +1.2% | −1.4% | +2.6% |
| 2022 | −37.9% | +2.5% | −40.4% |
| 2021 | +9.7% | +6.1% | +3.6% |
Source: Fund prospectus bar charts
Holdings overlap
7 of HELX's top 25 holdings also appear in FTXH's top 25.
| Holding | HELX | FTXH |
|---|---|---|
| United Therapeutics Corp | 3.51% | 2.72% |
| Eli Lilly & Company | 2.95% | 7.77% |
| Vertex Pharmaceuticals Inc | 2.75% | 3.41% |
| Medpace Holdings Inc | 2.15% | 1.41% |
| Neurocrine Biosciences Inc | 1.84% | 1.37% |
| Regeneron Pharmaceuticals Inc | 1.80% | 2.72% |
| Ptc Therapeutics Inc | 1.46% | 1.37% |
Source: SEC Form N-PORT
HELX top 10
- Guardant Health Inc — 9.09%
- Natera Inc — 7.46%
- Krystal Biotech Inc — 6.33%
- Ligand Pharmaceuticals Inc — 4.62%
- Adaptive Biotechnologies Corp — 3.99%
- United Therapeutics Corp — 3.51%
- Bridgebio Pharma Inc — 3.50%
- Eli Lilly & Company — 2.95%
- Twist Bioscience Corp — 2.85%
- Vertex Pharmaceuticals Inc — 2.75%
FTXH top 10
- Eli Lilly & Company — 7.77%
- Abbvie Inc — 7.39%
- Merck & Company Inc — 7.07%
- Johnson & Johnson — 6.96%
- Bristol-myers Squibb Company — 6.29%
- Biogen Inc — 3.84%
- Viatris Inc — 3.62%
- Cardinal Health Inc — 3.53%
- Vertex Pharmaceuticals Inc — 3.41%
- Amgen Inc — 3.18%
FAQ
What is the difference between HELX and FTXH?
Which is cheaper, HELX or FTXH?
Should I own both HELX and FTXH?
Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.